Prime Medicine, Inc. share price logo

Prime Medicine, Inc.

NASDAQ: PRME

Small Cap

$4.44

-0.28

(-5.93%)

as on

Prime Medicine, Inc. Stock Performance

as on November 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.36
    $4.81
    downward going graph

    1.80%

    Downside

    8.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.67
    $5.91
    downward going graph

    39.86%

    Downside

    33.11%

    Upside

    downward going graph

Prime Medicine, Inc. share price movements today

Previous Close
$4.72
Open
$4.75
Volume
3.9M
Market Cap
$856.1M
Day's Low - High
$4.36 - $4.81
52 Week Low - High
$2.67 - $5.91

Prime Medicine, Inc. Historical Returns

1 Month Return
+ 48.99 %
3 Month Return
+ 58.01 %
1 Year Return
-2.63 %
3 Year Return
-43.08 %
5 Year Return
0 %

Prime Medicine, Inc. Stock Fundamentals & Key Indicators

Check Prime Medicine, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$856.1M

EPS (TTM)

-1.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.29

Industry PE ratio

-7.24

PEG Ratio

-0.11

EBITDA

-180.5M

Revenue (TTM)

4.1M

Profit Margin

-1025.61%

Return On Equity TTM

-188.27%

Prime Medicine, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Prime Medicine, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$856.1MNA-4.29-1025.61%0.00%
Neutral$88.5B-36.16%-27.78-12.57%0.00%
StrongBuy$141.7B192.56%32.2786.04%0.00%
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Prime Medicine, Inc. Stock including INR - Dollar returns

The Prime Medicine, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Prime Medicine, Inc. investment value today

Current value as on today

₹1,03,971

Returns

₹3,971

(+3.97%)

Returns from Prime Medicine, Inc. Stock

-₹2,632 (-2.63%)

Dollar Impact

₹6,603 (+6.6%)

Analyst Recommendation on Prime Medicine, Inc. Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Prime Medicine, Inc.. Average target price of $7.3

Prime Medicine, Inc. Share Price Target

Get share price movements and forecasts by analysts on Prime Medicine, Inc..

What analysts predicted

39.18%UPSIDE

Target Price

$7.3

Current Price

$4.44

Analyzed by

6 Analysts

High

$9

Target

$7.30

Low

$5

Prime Medicine, Inc. target price $7.3, a slight upside of 39.18% compared to current price of $4.44. According to 6 analysts rating.

Indian Investors' Interest in Prime Medicine, Inc. Stock

Search interest for Prime Medicine, Inc. Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:126% versus previous 30 day period

Prime Medicine, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
-
0
2
1
1
1
0
0
1
Gross Profit
0
-
0
2
1
0
-42
0
-1
1
Operating Income
-48
-55
-54
-44
-52
-53
-53
-48
-50
-43
EBITDA
-44
-53
-50
-40
-50
-50
-48
-44
-47
-40
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-45
-55
-52
-42
-51
-52
-50
-46
-49
-42
Income Tax Expense
0
0
-
-
-
-
-
-
-
-
Net Income
-45
-55
-52
-42
-51
-52
-50
-46
-49
-42
Net Profit Margin
-122.50%
0.00%
100.00%
100.00%
100.00%
-67.17%
-3491.02%
100.00%
-116.82%
100.00%

Prime Medicine, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
5
-
-
-
2
4
Gross Profit
-2
2
-
-
-
2
-2
Operating Income
-2
0
-84
-116
-204
-202
-208
EBITDA
3
0
-165
-120
-186
-189
-195
Interest Expense
-
-
-
-
-
-
-
Depreciation
6
0
0
2
4
6
5
Income Before Tax
-2
-1
-165
-122
-198
-195
-201
Income Tax Expense
0
1
0
0
0
-
-
Net Income
-2
-3
-165
-121
-198
-195
-201
Net Profit Margin
0.00%
42.80%
0.00%
0.00%
0.00%
100.00%
-58.05%

Prime Medicine, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-45
-55
-52
-42
-51
-52
-50
-46
-49
-42
Operating Cash Flow
-67
-45
-25
16
-48
-41
-35
-37
-42
-41
Investing Cash Flow
-37
6
50
48
-47
2
-92
28
43
24
Financing Cash Flow
157
0
38
0
6
0
144
0
0
0
Change in Cash
52
-38
62
64
-90
-38
17
-8
1
-16

Prime Medicine, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-3
-165
-121
-198
-195
-201
Operating Cash Flow
-1
-5
-34
-131
-165
-122
-162
Investing Cash Flow
-
-1
-73
-47
18
68
-108
Financing Cash Flow
9
34
269
181
0
195
151
Change in Cash
-
28
161
2
-146
141
-119

Global Institutional Holdings in Prime Medicine, Inc.

Check out the Institutions with significant holdings in Prime Medicine, Inc..

Funds
Holdings
Robert Nelsen
10.20%
BlackRock, Inc.
5.29%
ARK
4.67%
Cathie Wood
4.60%
Vanguard
3.01%

Insights on Prime Medicine, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PRME stock has moved up by 49.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 789.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 227.9%

About Prime Medicine, Inc.

Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
OrganisationPrime Medicine, Inc.
Headquarters60 First Street, Cambridge, MA, 02141, US
IndustryBiotechnology
CEOAllan Reine

Key Management of Prime Medicine, Inc.

Name

Title

Dr. Matthew J. Hawryluk M.B.A., Ph.D.

Chief Business Officer

Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.

Executive Chair

Dr. Ann L. Lee Ph.D.

Chief Technical Officer

Dr. David R. Liu Ph.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Mohammed Asmal M.D., Ph.D.

Chief Medical Officer

Ms. Niamh Alix

Chief Human Resources Officer

Dr. Allan Reine M.D.

CEO & Director

Dr. Andrew Anzalone M.D., Ph.D.

Co-Founder & Head of Platform

Ms. Svetlana Makhni

Chief Financial Officer

Mr. Ryan E. Brown J.D.

Chief Legal Officer

FAQs

What is Prime Medicine, Inc. share price today?

Prime Medicine, Inc. share price today is $4.44 as on at the close of the market. Prime Medicine, Inc. share today touched a day high of $4.81 and a low of $4.36.

What is the 52 week high and 52 week low for Prime Medicine, Inc. share?

Prime Medicine, Inc. share touched a 52 week high of $5.91 on and a 52 week low of $2.67 on . Prime Medicine, Inc. stock price today i.e. is closed at $4.44,which is 24.87% down from its 52 week high and 66.29% up from its 52 week low.

What is Prime Medicine, Inc.'s market capitalisation today?

Prime Medicine, Inc. market capitalisation is $0.00T as on .

How to invest in Prime Medicine, Inc. Stock (PRME) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Prime Medicine, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Prime Medicine, Inc. Stock (PRME) from India?

Indian investors can start investing in Prime Medicine, Inc. (PRME) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Prime Medicine, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Prime Medicine, Inc. share’s latest price of $4.44 as on November 3, 2026 at 8:46 am IST, you will get 2.2523 shares of Prime Medicine, Inc.. Learn more about fractional shares .